glp 1 agonist fda approval Approves First Generic Daily GLP-1 Injection for Type 2 Diabetes FDA Approves Foundayo, First Non-Peptide

Bilirubin is measured as total bilirubin and direct bilirubin

If transitioning from subcutaneous to nasal administration, start at your established injectable dose and adjust based on response rather than assuming a specific conversion ratio

Comparison with Other Vitamin B12 Forms Hydroxocobalamin versus Methylcobalamin Hydroxocobalamin is preferred in clinical practice for injections because it lasts longer and has higher bioavailability

Some common side effects include: By mouth: nausea, vomiting, diarrhea, or constipation Intravenously (IV): rash, fever, headache, drowsiness, low blood pressure, and liver problems By inhalation: swelling in the mouth, runny nose, drowsiness, clamminess, and chest tightness Storage Store at controlled room temperature